Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer [Phase 1, Phase 2]
Completed Phase I/II study of nivolumab, ipilimumab, and plinabulin in recurrent small cell lung cancer; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Small Cell Lung Carcinoma Trial With Nivolumab and IpiliMUmab in LImited Disease [Phase 2]
This Phase 2 trial update reports results for nivolumab plus ipilimumab in limited-stage small cell lung cancer (NCT02046733), with results …
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Atezolizumab Combined With Chemotherapy in Extensive Stage SCLC
This document reports the completion of a clinical trial evaluating atezolizumab combined with chemotherapy for extensive-stage small cell l…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours [Phase 1]
This clinical trial update reports the completion of a first-in-human Phase 1 study evaluating AZD8701 with or without durvalumab in adults …
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Testing a Cognitive Behavioral Model for Reducing Dyspnea in Patients With Lung Cancer [NA]
A completed study evaluating a cognitive-behavioral model to reduce dyspnea in patients with lung cancer has been reported.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors. [Phase 1, Phase 2]
Clinical trial update reporting safety, pharmacokinetics, and efficacy findings for tinostamustine in patients with advanced solid tumors, i…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: AMG 757 and AMG 404 in Subjects With Small Cell Lung Cancer (SCLC) [Phase 1]
Phase 1 clinical trial update showing results for Amgen’s AMG 757 and AMG 404 in Small Cell Lung Cancer; results were posted in October 2024…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial of JK08 for unresectable locally advanced or metastatic cancer conducted by Salubris Biotherapeutics is cur…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: DS-3201b and Irinotecan for Patients With Recurrent Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating DS-3201b in combination with irinotecan for recurrent small cell lung cancer has been terminated, with results po…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors [Phase 1, Phase 2]
Phase I/II trial evaluating the safety and preliminary activity of nivolumab combined with vorolanib in patients with refractory thoracic tu…
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2 [Phase 1]
Phase 1 clinical trial evaluating the GD2-SADA:177Lu-DOTA complex in GD2-expressing solid tumors is currently recruiting, including small ce…
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: A Phase II Study of Ivonescimab Combined with Cadonilimab and Chemotherapy in Extensive-stage Small Cell Lung Cancer [Phase 2]
Phase II study evaluating Ivonescimab in combination with Cadonilimab and chemotherapy for extensive-stage small cell lung cancer; the trial…
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: Berzosertib + Topotecan in Relapsed Platinum-Resistant Small-Cell Lung Cancer (DDRiver SCLC 250) [Phase 2]
A Phase 2 trial evaluating the combination of berzosertib and topotecan in relapsed platinum-resistant small-cell lung cancer has completed,…
-
CLINICAL_TRIALS trial_result · 2024-09-20Clinical Trial Update: Docetaxel - Carboplatin As Second Line Treatment in Patients with Small Cell Lung Cancer [Phase 2]
A phase 2 trial evaluating docetaxel plus carboplatin as second-line treatment for small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: IMP4297 in Combination With Temozolomide in Patients With Advanced Solid Tumors and Small Cell Lung Cancer [Phase 1, Phase 2]
IMP4297 combined with temozolomide was studied in patients with advanced solid tumors and small cell lung cancer in Phase 1/Phase 2 trials, …
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors [Phase 1]
Phase 1 study shows safety, pharmacokinetics and preliminary anti-tumor activity of RP12146 in patients with solid tumors, including extensi…
-
CLINICAL_TRIALS trial_result · 2024-09-05Clinical Trial Update: A Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based Chemotherapy [Phase 2]
Phase 2 trial comparing TAS-102 with topotecan or amrubicin for small cell lung cancer after platinum therapy has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-09-04Clinical Trial Update: Trial of BMS-986012 in Combination With Platinum and Etoposide [Phase 1]
This document reports the completion of a Phase 1 trial evaluating the investigational antibody BMS-986012 in combination with a platinum ag…
-
CLINICAL_TRIALS trial_result · 2024-09-03Clinical Trial Update: JK-1201I Compared with Topotecan in Patients with Relapsed Extensive Stage Small Cell Lung Cancer [Phase 3]
Phase 3 trial comparing JK-1201I versus Topotecan in relapsed extensive-stage small cell lung cancer; the study is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-08-26Clinical Trial Update: A Safety, Tolerability and Preliminary Efficacy Evaluation of CC-90011 Given in Combination With Cisplatin and Etoposide in Subjects With First Line, Extensive Stage Small Cell Lung Cancer [Phase 1]
A Phase 1 trial evaluating safety, tolerability, and preliminary efficacy of CC-90011 in combination with cisplatin and etoposide as first-l…
-
CLINICAL_TRIALS trial_result · 2024-08-23Clinical Trial Update: QUILT-2.013: First-Line Treatment for Extensive Stage Small Cell Lung Cancer [Phase 1, Phase 2]
This entry reports on the QUILT-2.013 first-line treatment study for extensive-stage small cell lung cancer (Phase 1/2) sponsored by NantCel…
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Hypofraction Radiotherapy for Limited-Stage Small Cell Lung Cancer [NA]
This completed clinical trial evaluates hypofractionated radiotherapy for limited-stage small cell lung cancer, reporting on safety and effi…
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: Study of Durvalumab in Combination With Platinum and Etoposide for the First Line Treatment of Patients With Extensive-stage Small Cell Lung Cancer [Phase 3]
Phase 3 trial update reporting results for durvalumab in combination with platinum and etoposide as first-line therapy for extensive-stage s…
-
CLINICAL_TRIALS trial_result · 2024-08-13Clinical Trial Update: Real-life Second-line Epirubicin-Paclitaxel Regimen as Treatment of Relapsed Small-Cell Lung Cancer : EpiTax Study.
The EpiTax study (NCT06550518) reports completion of a real-world evaluation of a second-line epirubicin-paclitaxel regimen for relapsed sma…
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: SHR-1210 Combined With Apatinib in Treatment of ED-SCLC After Failure of First Line Standard Therapy [Phase 2]
Phase 2 trial evaluating the combination of camrelizumab (SHR-1210) and apatinib in extensive-disease small-cell lung cancer after failure o…